Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $227,039 - $267,239
-2,344 Reduced 34.73%
4,406 $446,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $294,971 - $346,046
3,103 Added 85.08%
6,750 $741,000
Q3 2022

Oct 06, 2022

BUY
$96.76 - $112.03 $68,022 - $78,757
703 Added 23.88%
3,647 $353,000
Q2 2022

Jul 14, 2022

BUY
$102.07 - $123.37 $8,675 - $10,486
85 Added 2.97%
2,944 $320,000
Q1 2022

Apr 28, 2022

SELL
$114.02 - $139.04 $13,568 - $16,545
-119 Reduced 4.0%
2,859 $338,000
Q4 2021

Jan 27, 2022

BUY
$115.53 - $141.46 $14,441 - $17,682
125 Added 4.38%
2,978 $419,000
Q3 2021

Oct 25, 2021

SELL
$116.66 - $129.06 $14,349 - $15,874
-123 Reduced 4.13%
2,853 $337,000
Q2 2021

Jul 20, 2021

BUY
$105.79 - $124.53 $39,988 - $47,072
378 Added 14.55%
2,976 $345,000
Q1 2021

Apr 21, 2021

SELL
$108.84 - $128.23 $1,959 - $2,308
-18 Reduced 0.69%
2,598 $311,000
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $1,890 - $2,059
-18 Reduced 0.68%
2,616 $286,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $241,379 - $293,137
2,634 New
2,634 $287,000
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $106,993 - $121,208
-1,632 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $99,241 - $119,723
1,632 New
1,632 $120,000
Q2 2018

Aug 15, 2018

SELL
$57.57 - $63.54 $93,493 - $103,188
-1,624 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $63,020 - $67,469
-1,174 Reduced 41.96%
1,624 $93,000
Q3 2017

Nov 15, 2017

BUY
$48.06 - $53.64 $14,754 - $16,467
307 Added 12.32%
2,798 $149,000
Q2 2017

Aug 15, 2017

BUY
N/A
2,491
2,491 $121,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.